Genocea Biosciences To Present At The 2015 Biotechnology Industry Organization (BIO) CEO & Investor Conference

Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing T cell-directed vaccines and immunotherapies, today announced that Chip Clark, president and chief executive officer, will present a company overview at the upcoming 2015 BIO CEO & Investor Conference. The presentation is scheduled for Monday, February 9, 2015 at 8:30 a.m. EST in New York, NY.

Help employers find you! Check out all the jobs and post your resume.

Back to news